Top compounds associated with response to NAT9


Feature Type Standardized
Nominal ANOVA
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.078 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.03
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.075 0.03
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.15 0.03
mRNA birinapant CTRPv2 pan-cancer AAC -0.082 0.03
mRNA Nutlin-3 CCLE pan-cancer AAC -0.1 0.03
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC -0.1 0.03
mRNA MK-2206 GDSC1000 pan-cancer AAC -0.077 0.03
mRNA Sorafenib CCLE pan-cancer AAC -0.097 0.03
Download CSV